
Opinion|Videos|December 20, 2024
Important Background Information on RSV for Pharmacists
Traci M. Poole, PharmD, BCACP, BCGP, discusses the pathophysiology of respiratory syncytial virus (RSV) and its key complications, identifies high-risk populations for severe RSV infection, and explores best practices for recognizing these patients and ensuring they receive timely vaccination to prevent serious outcomes.
Advertisement
Episodes in this series

Now Playing
Video content above is prompted by the following:
- What is the pathophysiology of RSV, and what key complications may occur?
- What are the high-risk populations for getting severe RSV infection?
- What are the best practices for identifying these patients and ensuring they are vaccinated against RSV?
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Once-Weekly Retatrutide Reduces Weight and Knee Pain in Patients With Obesity and Osteoarthritis
2
FDA Approves Lerodalcibep for Hypercholesterolemia and Heterozygous Familial Hypercholesterolemia
3
FDA Approves T-DXd With Pertuzumab for First-Line Treatment of Advanced HER2+Breast Cancer
4
FDA Approval Signals Broader Recognition of Sexual Health in Aging Women
5
















































































































































































































